Amlodipine And Olmesartan Medoxomil recalls
Amlodipine And Olmesartan Medoxomil products have been recalled 7 times, most recently on 28 Oct 2026. The recalling company is usually Ascend Laboratories. The most common reason is potency & assay.
Total recalls7since 2018
Last 12 months3reported
Class I00% of total
Ongoing4latest 28 Oct 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 6 86%Class III 1 14%
Why amlodipine and olmesartan medoxomil is recalled
Companies
Product types
By year
Ongoing amlodipine and olmesartan medoxomil recalls
4 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Amlodipine and Olmesartan Medoxomil Tablets, 10mg/40mg recalledAmlodipine And Olmesartan Medoxomil | Ascend Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg recalledAmlodipine And Olmesartan Medoxomil | Ascend Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg recalledAmlodipine And Olmesartan Medoxomil | Ascend Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg recalledAmlodipine And Olmesartan Medoxomil | Ascend Laboratories | Potency & Assay | Nationwide |
All amlodipine and olmesartan medoxomil recalls, newest first
7 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.